Result of AGM

DXS INTERNATIONAL PLC (AQSE: DXSP)Result of DXS AGM 2024 The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce that all resolutions put to shareholders at the Company's annual general meeting ("AGM") held yesterday were duly passed.All resolutions were passed on a poll and the votes received from shareholders on each resolution put to the AGM...

Elstead, 20/12/2024 (informazione.it - comunicati stampa - salute e benessere)

DXS INTERNATIONAL PLC

(AQSE: DXSP)

Result of DXS AGM 2024

The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce that all resolutions put to shareholders at the Company's annual general meeting ("AGM") held yesterday were duly passed.

All resolutions were passed on a poll and the votes received from shareholders on each resolution put to the AGM are set out below.

Resolution	Votes for *	%	Votes against	%	Votes withheld **

Resolution 1	13,664,949	100.00%	0	0.00%	0
Resolution 2	13,664,949	100.00%	0	0.00%	0
Resolution 3	13,657,059	99.94%	5,000	0.04%	2,890
Resolution 4	13,659,949	99.96%	5,000	0.04%	0
Resolution 5	13,609,949	99.60%	55,000	0.40%	0
Resolution 6	13,659,949	99.96%	5,000	0.04%	0

* Includes discretionary votes

** A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" any of the resolutions

During the AGM, the Company's CEO, David Immelman, provided an update on DXS's progress. The Presentation is available for download from the Company's website at https://www.dxs-systems.co.uk/corporate-documents.php No new information was provided in this presentation.

The Directors of DXS International plc accept responsibility for this announcement.

Contacts:

David Immelman DXS International plc www.dxs-systems.com	01252 719800
AQSE Corporate Broker and Corporate Advisor Hybridan LLP Claire Louise Noyce	020 3764 2341

Notes to Editors

About DXS:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.